https://www.psychdb.com/ 2026-07-17T22:00:19-0700 https://www.psychdb.com/ https://www.psychdb.com/lib/tpl/bootstrap3/images/favicon.ico text/html 2026-07-02T01:42:31-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/mood/1-depression/perimenopausal?rev=1782981751&do=diff Perimenopausal Depression Primer Perimenopausal Depression is a subtype of depression experienced by women during the perimenopausal period, defined as the interval when a women’s menstrual cycles become irregular, usually between ages of 45 and 49. Definition text/html 2026-07-01T23:59:33-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/teaching/biopsychosocial-case-formulation?rev=1782975573&do=diff Biopsychosocial Model and Case Formulation Primer The Biopsychosocial Model and Case Formulation (also known as the Biopsychosocial Formulation) in psychiatry is a way of understanding a patient as more than a diagnostic label. Hypotheses are generated about the origins and causes of a patient's symptoms. The most common and clinically practical way to formulate is through the biopsychosocial approach, first described in 1980 by George Engel. text/html 2026-06-07T22:28:14-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/meds/antipsychotics/eps?rev=1780896494&do=diff Extrapyramidal Symptoms (EPS) Primer Extrapyramidal Symptoms (EPS) are drug-induced movement disorders that occur due to antipsychotic blockade of the nigrostriatal dopamine tracts. These blockades can lead to increased cholinergic activity, resulting in acute dystonia, acute akathisia, antipsychotic-induced parkinsonism, tardive dyskinesia (TD), tardive dystonia, and tardive akathisia. text/html 2026-05-28T00:31:57-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/psychotherapy/psychodynamic/home?rev=1779953517&do=diff Explores unconscious conflicts that cause symptoms and explores past relationships, transference, and defense mechanisms. text/html 2026-05-25T00:28:30-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/geri/parkinsons?rev=1779694110&do=diff Parkinson's Disease (PD) Primer Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by a loss of dopaminergic innervation in the basal ganglia leading to motor and non-motor symptoms. Although historically considered a motor disorder, there are many neuropsychiatric symptoms associated with the disease, and the majority of diagnoses will progress to text/html 2026-05-24T22:02:03-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/brain-stimulation/rtms?rev=1779685323&do=diff Repetitive Transcranial Magnetic Stimulation (rTMS) Primer Repetitive Transcranial Magnetic Stimulation (rTMS) is a form of brain stimulation that uses focused magnetic field pulses to induce electrical currents in neural tissue non-invasively, via an inductor coil positioned against the scalp.<ul id="frontpage "style="column-width:20em; -webkit-column-count: 1; -moz-column-count: 1; column-count: 1;" class="catlist_columns catlist-nslist" ><ul id="frontpage"><li class="catlist-head"><div clas… text/html 2026-05-18T16:04:12-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/meds/pharmacology/placebo-effect?rev=1779145452&do=diff The Placebo Effect Primer The Placebo Effect is the tendency of any medication or treatment, even an inert or ineffective one, to exhibit results simply because the recipient believes that it will work. Placebo Response Rates * The largest meta-analysis of the placebo effect in psychiatric randomized control trials found that patients with text/html 2026-04-19T23:20:48-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/addictions/stimulants/1-use-disorder?rev=1776666048&do=diff Stimulant Use Disorder Primer Stimulant Use Disorder is a substance use disorder characterized by a problematic pattern of stimulant use leading to clinically significant impairment or distress. For a pharmacological review of prescribed stimulants, see: Introduction to Stimulants <ul id="frontpage "style="column-width:20em; -webkit-column-count: 1; -moz-column-count: 1; column-count: 1;" class="catlist_columns catlist-nslist" ><ul id="frontpage"><li class="catlist-head"><div class="entity-li… text/html 2026-04-11T17:13:05-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/meds/antipsychotics/first-gen-typical/4-zuclopenthixol?rev=1775952785&do=diff Zuclopenthixol (Clopixol-Depot, Clopixol-Acuphase) Primer Zuclopenthixol (Tradename: Clopixol) is a typical antipsychotic that comes in two formulations. Zuclopenthixol decanoate (Cloxpiol Depot) is for long-term treatment of schizophrenia, while zuclopenthixol acetate<ul id="frontpage "style="column-width:20em; -webkit-column-count: 1; -moz-column-count: 1; column-count: 1;" class="catlist_columns catlist-nslist" ><ul id="frontpage"><li class="catlist-head"><div class="entity-list-item"><span… text/html 2026-04-07T15:38:56-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/teaching/bc/mha/form-20?rev=1775601536&do=diff bc-mha-forms Form 20 (British Columbia - Leave Authorization), Extended Leave, and Recalls Primer A Form 20 (Leave Authorization), also known as Extended Leave (EL), is a form under the British Columbia Mental Health Act that is completed and allows an involuntary patient to leave the hospital and live in the community. Under this Form, a patient will return to live in the community (i.e. - home), but are still legally considered an admitted and involuntary patient. Note that Extended Leave i… text/html 2025-06-03T18:11:22-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=teaching%3Aon%3Amha%3Aform_1_and_42_-_explained.pdf&ns=teaching%3Aon%3Amha&rev=1748999482&tab_details=history&mediado=diff&do=media text/html 2024-09-03T02:22:16-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=mood%3Aranzcp-depression-guidelines.pdf&ns=mood&rev=1725355336&tab_details=history&mediado=diff&do=media text/html 2024-07-10T14:19:12-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=teaching%3Abc%3Amha%3Aform_5_quick_guide.pdf&ns=teaching%3Abc%3Amha&rev=1720646352&tab_details=history&mediado=diff&do=media text/html 2024-07-10T14:15:17-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=teaching%3Abc%3Amha%3Aform_4.2_quick_guide.pdf&ns=teaching%3Abc%3Amha&rev=1720646117&tab_details=history&mediado=diff&do=media text/html 2024-07-10T14:14:53-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=teaching%3Abc%3Amha%3Aform_4.1_quick_guide.pdf&ns=teaching%3Abc%3Amha&rev=1720646093&tab_details=history&mediado=diff&do=media text/html 2023-06-30T21:59:57-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=sleep%3Asleep_changes_with_age.png&ns=sleep&rev=1688187597&tab_details=history&mediado=diff&do=media <img src="https://www.psychdb.com/_media/sleep/sleep_changes_with_age.png?w=500&h=319&t=1688187597&amp;tok=bdd6f6" alt="sleep:sleep_changes_with_age.png" /> text/html 2023-04-06T13:49:30-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=teaching%3Abc%3Amha%3Aform_4.1_bc.pdf&ns=teaching%3Abc%3Amha&rev=1680814170&tab_details=history&mediado=diff&do=media text/html 2023-04-06T13:49:30-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=teaching%3Abc%3Amha%3Aform_4.2_bc.pdf&ns=teaching%3Abc%3Amha&rev=1680814170&tab_details=history&mediado=diff&do=media text/html 2023-02-19T16:28:50-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=cl%3Ahyperparathyroidism.jpg&ns=cl&rev=1676852930&tab_details=history&mediado=diff&do=media <img src="https://www.psychdb.com/_media/cl/hyperparathyroidism.jpg?w=500&h=308&t=1676852930&amp;tok=3790fd" alt="cl:hyperparathyroidism.jpg" /> text/html 2023-02-19T16:26:23-0700 psychdb (psychdb@undisclosed.example.com) https://www.psychdb.com/?image=neurology%3Aumn_vs_lmn_lesion.jpg&ns=neurology&rev=1676852783&tab_details=history&mediado=diff&do=media <img src="https://www.psychdb.com/_media/neurology/umn_vs_lmn_lesion.jpg?w=337&h=500&t=1676852783&amp;tok=3e19d5" alt="neurology:umn_vs_lmn_lesion.jpg" />